 tonic pain percept mous differenti modul receptor-select opioid agonist proposit tonic nocicept model analog clinic pain tradit acut model previou develop mous paw formalin test possibl modulatori role site action endogen opioid system receptor-pref agonist mu kappa enkephalin dpdpe delta antinocicept activ formalin paradigm system dpdpe spinal supraspin rout observ blind condit overt behavior breach receptor specif observ period dose dpdpe micrograms/mous intrathec micrograms/mous intracerebroventricular behavior syndrom mu agon studi accept dose rang mean percent analgesia reduct paw control trans- cyclohexyl -benzeneacetamid methanesulfon nmol/kg subcutan nmol/kg intrathec nmol/kg intracerebroventricular sufentanil nmol/kg subcutan nmol/kg intrathec dpdpe inact basi dose-respons data mice kappa mu delta opioid receptor tonic pain percept spinal supraspin loci result inclus modifi formalin test preclin evalu potenti kappa agonist